Gunderson Dettmer Advises Aldeyra Therapeutics, Inc. on Underwritten Public Offering

January 20, 2021Client News

Gunderson Dettmer advised client Aldeyra Therapeutics, Inc. on its underwritten public offering of 7,868,421 shares of its common stock (including full exercise of the underwriters’ option to purchase additional shares) at the price to the public of $9.50 per share for a total of $74.7 million in aggregate gross proceeds.

Jefferies LLC and SVB Leerink LLC acted as joint book-running managers for the offering. BTIG LLC and Oppenheimer & Co. Inc. acted as co-lead managers for the offering.

The Gunderson deal team included corporate partner Jay Hachigian, of counsel Keith Scherer and corporate associate John Maciejewski.